Rule 506(b); Investment Company Act Section 3(c)(1); Investment Company Act Section 3(c)(7)
First filed
2021-05-14
Latest filing
2021-05-14
First sale
2021-04-30
Filings
1 Form D
People
Named in Item 3 of its latest Form D, filed 2021-05-14
Related persons
Name
Relationship
Clarification
venBio Global Strategic GP IV, LLC
RelationshipPromoter
ClarificationGeneral Partner of the Issuer
venBio Management Company LLC
RelationshipExecutive Officer
ClarificationManager of the Issuer
Corey Goodman
RelationshipExecutive Officer
Clarification—
Robert Adelman
RelationshipExecutive Officer
Clarification—
Aaron Royston
RelationshipExecutive Officer
Clarification—
Richard Gaster
RelationshipExecutive Officer
Clarification—
David Pezeshki
RelationshipExecutive Officer
Clarification—
Sales compensation
Named in Item 12 of its Form D filings
Sales compensation recipients
Recipient
CRD
Broker-dealer
Offerings
BA Securities LLC
CRD153489
Broker-dealer—
Offerings1
Far Hills Group, LLC
CRD32243
Broker-dealer—
Offerings1
History
2021-05-14Form D filed · 021-399537
The other funds of Venbio Partners LLC (5 on Form ADV) and every Form D as filedSee plans
The firm and the filings behind venBio Global Strategic Fund IV, L.P.
A fund's Form D states its target and what it has sold so far. The dashboard puts it beside the adviser's other funds from Form ADV, the startups linked to it, and every amendment as filed.
The adviser's Venture page: its Form ADV funds, assets and other Form D offerings
Where co-filings link it, the startups this fund backed
Every Form D and amendment as filed, with what each one stated
Everyone its filings name, linked to their other funds and companies
Part of the Venture plan — $140/mo at launch pricing ($350 list)